fasting and tirzepatide Media Centre fasting while on tirzepatide Tirzepatide

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for chronic weight management) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist

The FDA collected 480 adverse event reports for compounded tirzepatide products, but these reports do not distinguish between problems caused by tirzepatide itself versus problems caused by contamination, incorrect dosing, or inactive ingredients in the compounded formulation

The jump from 2.5mg to 5mg doubles the receptor activation, and the clinical data reflects this

Follow the links to fill out an E-Consult form on your schedule, not ours

Other diabetes medications or weight management strategies may be appropriate depending on individual clinical circumstances

It is available at Dr